An Emergency Use Authorization (EUA) authorizes the use of unapproved medical products or unapproved uses of approved medical products during a declared public health emergency.
Of the 39 percent who reported they do not plan to get the shot, 13 percent said they would if their employer offered it.
A paper published in Nature identifies two promising odor compounds that may be a less expensive way to reduce mosquito-borne diseases -- by turning off the mosquitoes' mechanism for detecting carbon dioxide.
Candidates must be a member of the health care organization's executive team who has made infection prevention an organizational priority, supported programs to target zero health care-associated infections (HAIs), and reduced the transmission of one or more HAIs within their facility.
The Sept. 2-3 meeting will produce new treatment guidelines and guidance on identifying surge capacity for hospitals during a severe outbreak, said Dr. David Butler-Jones, Canada's chief public health officer.
The update responds to recommendations from the President's Council of Advisors on Science and Technology, which completed a report on flu readiness that is also on the White House Web site.
Getting federal employees ready for pandemic flu is the subject of a draft report OSHA's Federal Advisory Council on Occupational Safety and Health will consider next month.
Duke University Medical Center researchers report in Nature that the marker is a single letter change -- a C instead of a T -- in a segment of DNA near the IL28B gene.
Three cabinet secretaries, including HHS' Kathleen Sebelius, urged businesses to plan for absences, encourage employees to be vaccinated, and ensure critical operations are not interrupted.
With a very challenging flu season ahead, year two of the Joint Commission Resources' Flu Vaccination Challenge has a goal of building on last year's success at raising the flu vaccination rate among U.S. health care workers.
In the latest installment of "The Researcher's Perspective," the new podcast series by Environmental Health Perspectives (EHP), Dr. Josh Hamilton discusses the potential implications of his recent mouse study on arsenic exposure and immune response to influenza A/H1N1.
The company began U.S. clinical trials Aug. 6 and plans to test the vaccine's immunogenicity and safety, with about 2,000 people getting it in the trials.
By Sept. 1, the 14-member committee will provide a letter report to CDC and OSHA addressing personal protective equipment needs for this crucial workforce.
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) met recently to make recommendations for use of vaccine against novel influenza A (H1N1), including who should receive vaccine against novel influenza when it becomes available and which groups of the population should be prioritized if the vaccine is initially available in extremely limited quantities.
Safety authorities around the world, working together in some cases, have focused recently on health issues, construction falls, hospital-associated infections, and aviation safety.
The Food and Drug Administration today announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.
The findings are a significant improvement over a similar 2005 study in which more than 40 percent of public health employees said they were unlikely to report to work during a pandemic emergency.
The prospect of winning $2,500 and national TV exposure for a 15- or 30-second flu video in the HHS contest enticed 20 entries in its first two weeks.
Dr. Anne Schuchat today said CDC recommends about 83 percent of the U.S. population get the seasonal flu vaccine, but only 40 percent did last year. Health care workers should get it and also the H1N1 vaccine when it's ready.
The Food and Drug Administration recently announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States.